Modafinil and Buprenorphine: Interaction Details
- Buprenorphine
- ButransBelbucaSublocade +2 more
- Modafinil
- Provigil
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Modafinil and Buprenorphine interaction:
Buprenorphine
- Butrans
- Belbuca
- Sublocade
- Buprenex
- Brixadi
What Happens When You Take Modafinil With Buprenorphine
What can happen when they are taken together (rated Major)
Reduced buprenorphine exposure and reduced of buprenorphine
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Giving buprenorphine together with a can lower buprenorphine , which may lead to withdrawal symptoms. When a patient on buprenorphine must also take a CYP3A4 inducer, a buprenorphine dose increase can be considered until the drug effects are stable, along with monitoring for withdrawal.
If the CYP3A4 inducer is later stopped in a patient on buprenorphine, consider lowering the buprenorphine dose and monitor for .1 Should the dose be impossible to adjust once the inducer is no longer present, the patient should be moved back to a buprenorphine formulation that allows finer dose adjustment.
For patients switched from transmucosal buprenorphine taken with CYP3A4 , monitoring is needed to confirm that the plasma buprenorphine level achieved with subQ buprenorphine is sufficient. Patients already receiving subQ buprenorphine who need a CYP3A4 inducer should be monitored for withdrawal.
If the buprenorphine dose proves inadequate while the interacting medication is on board, and that medication cannot be reduced or stopped, the buprenorphine dose should be adjusted. When the available doses cannot reach the dose that is needed, treat the patient with a buprenorphine formulation that allows more precise dose adjustment.2
The Modafinil and Buprenorphine Interaction, Explained
Modafinil can lower the amount of buprenorphine in your body. Modafinil speeds up an enzyme in the liver () that breaks buprenorphine down, so the medicine may not work as well. Some people notice withdrawal symptoms, such as restlessness, sweating, achiness, stomach upset, or cravings, or pain that is less well controlled.
Keep taking both medicines as prescribed and tell your pharmacist or doctor that you use both. Your care team can manage this by adjusting your buprenorphine dose and checking in with you more closely. If modafinil is ever stopped, let them know, because your dose may need to be adjusted again.
Modafinil ( ) may reduce buprenorphine exposure, increasing the risk of reduced and withdrawal. Buprenorphine is a CYP3A4 (to norbuprenorphine). Evidence is rated probable and the severity is major. Onset is unspecified, and typically develops over days to weeks. A specific magnitude is not documented here.
- If the inducer is necessary, consider increasing the buprenorphine dose until effects are stable, and monitor for withdrawal.
- On discontinuing the inducer, consider a buprenorphine dose reduction and monitor for .
- If available strengths do not allow adequate dose adjustment, use a formulation permitting more precise .
- For subQ buprenorphine, monitor for withdrawal, and confirm adequacy of after conversion from transmucosal dosing with .
See the 2 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Modafinil and Buprenorphine Interact
The likely mechanism
of -mediated of buprenorphine
How to Manage the Modafinil and Buprenorphine Interaction
Your care team can manage this by tailoring your buprenorphine dose and monitoring you.
- Keep taking both medicines exactly as prescribed, and do not change doses on your own.
- Your team may increase your buprenorphine dose and check for withdrawal symptoms until things are stable.
- If modafinil is stopped, your buprenorphine dose may need to be lowered, and your team may watch for slowed breathing or unusual drowsiness.
- If your available doses do not allow fine adjustment, your team may switch to a different buprenorphine form.
- Tell your pharmacist or prescriber about any withdrawal symptoms, returning pain, or cravings.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Modafinil or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: BRIXADI subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection
The influence of a coadministered on buprenorphine exposure has not been examined in subjects receiving subQ buprenorphine; however, such interactions have been demonstrated in studies of transmucosal buprenorphine. The effects of buprenorphine may vary depending on the route of administration.2
Modafinil and Buprenorphine: Common Questions
How serious is the Modafinil and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Modafinil and Buprenorphine interaction managed?
Your care team can manage this by tailoring your buprenorphine dose and monitoring you. Keep taking both medicines exactly as prescribed, and do not change doses on your own. Your team may increase your buprenorphine dose and check for withdrawal symptoms until things are stable. If modafinil is stopped, your buprenorphine dose may need to be lowered, and your team may watch for slowed breathing o… Management is individual — always follow your own care team's guidance.
Does taking Modafinil and Buprenorphine at different times of day help?
No. Taking them at different times of day does not prevent this one. Modafinil speeds up , an enzyme that breaks down buprenorphine, so buprenorphine can be cleared faster. That change lasts while modafinil is being taken and can continue for a while after the last dose.
Your pharmacist or prescriber can tell you how they will manage it.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Modafinil and Buprenorphine Interaction
Ask in your own words about taking Modafinil and Buprenorphine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (2)
- Product Information: ZUBSOLV(R) sublingual tablets, buprenorphine naloxone sublingual tablets. Orexo US Inc (per FDA), Morristown, NJ, 2023. DailyMed
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
Other Serious Interactions of Modafinil and Buprenorphine
Also serious with Buprenorphine
- DronedaroneContraindicated
- FluconazoleContraindicated
- IsocarboxazidContraindicated
- KetoconazoleContraindicated
Also serious with Modafinil
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Buprenorphine
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- KavaMajor
- WineMajor
- 1,4-butanediolMajor
- BeerMajor
- Gamma-hydroxybutyrate (GHB)Major
- + 210 more
With Modafinil
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- AdrafinilMajor
- EphedraMajor
- PeyoteMajor
- Rauvolfia VomitoriaMajor
- Sida CordifoliaMajor
- + 194 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.